image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Playtech

May 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PTEC
  • Price:
  • 460p
Results were in-line at EBITDA of €432m (+9%). Of that, B2C EBITDA (Snaitech) rose 6% to €250m, slightly impacted by a run of customer friendly sporting results in H2. In B2B, EBITDA rose 14% to €182m with Americas revenue up 46% and 30% of division total. Brazil is going well while Playtech is licensed in 11 US states with three Live Casinos up and running. But overshadowing everything is that major customer Caliente is refusing to pay €87m due to its long running dispute. Caliente argues it had the right to buy Playtech’s interest in their online Mexican joint venture, CaliPlay, which attempted to list in New York via a SPAC but Playtech says those rights had expired. Caliente’s subsequent action has diverted fees due to Playtec ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe